Laboratory

Precision Point Diagnostics

1 panel

Test panels by Precision Point Diagnostics

1 panel offered by this laboratory

Precision Point Diagnostics: Advanced IBA Profile for Intestinal Barrier Assessment The Advanced Intestinal Barrier Assessment (IBA) profile from Precision Point Diagnostics offers an in-depth evaluation of intestinal barrier function. By utilizing a collection of innovative biomarkers, this test helps clinicians determine if their patients are experiencing intestinal permeability, commonly known as "leaky gut." Intestinal permeability is often linked to autoimmune diseases, systemic inflammation, and food sensitivities. Addressing gut barrier health is critical for resolving chronic diseases—without proper gut healing, other treatments may have limited effectiveness. Key Biomarkers in the Advanced IBA Profile The Advanced IBA profile features unique and clinically relevant markers that provide a comprehensive view of gut barrier health: Histamine & Diamine Oxidase (DAO): These markers offer insights into histamine regulation and the health of the gut mucosa. Plasma Zonulin: A reliable indicator of intestinal tight junction integrity, Plasma Zonulin is the preferred marker for assessing gut barrier function. Lipopolysaccharides (LPS) & LPS Antibodies: LPS, produced by gram-negative bacteria, are endotoxins that can contribute to inflammation. LPS antibodies provide valuable information about intestinal permeability and associated inflammatory responses. This test is beneficial for patients suffering from allergies, food sensitivities, digestive issues, headaches, cognitive decline, depression, and other related conditions (refer to the Table of Associated Symptoms and Conditions for more details). Personalized Treatment Plans Based on IBA Results The Advanced IBA profile enables clinicians to develop tailored treatment plans based on each patient's specific test results, ensuring more effective and targeted interventions. Since no two patients are the same, protocols to improve intestinal permeability must be individualized. The Advanced IBA profile helps identify the root cause of barrier dysfunction, making treatment more efficient, cost-effective, and successful. Some patients may need to focus on balancing DAO and histamine levels, while others may need to address the underlying causes of Zonulin elevation or high LPS antibodies. With this precise approach, clinicians can effectively address the root causes of intestinal permeability and guide their patients back to health. By using the Advanced IBA profile, practitioners can pinpoint and treat intestinal permeability issues, ultimately helping their patients achieve long-term wellness.